Novartis culls ianalumab in HS after Phase IIb trial failure
The study (NCT03827798) had enrolled 248 patients with HS and was evaluating the change in simplified Hidradenitis Suppurativa Clinical Response (sHiSCR) after 16 weeks.
The termination of the therapy in HS was announced in Novartis' Q2 results, with the company stating: 'Novartis will not advance investigation of ianalumab in HS following a Phase II proof-of-concept study which did not meet our target criteria despite demonstrating efficacy vs placebo. No new safety signals were observed, and all other studies for ianalumab in B-cell driven diseases continue as planned.'
The indications Novartis will continue the development of ianalumab for include lupus nephritis, Sjögren syndrome, and autoimmune hepatitis.
Ianalumab is a monoclonal antibody directed against the BAFF (B cell-activating factor belonging to the TNF family) receptor. It acts by preventing the activation of B cells to avoid overproduction. By reducing the number and activity of B cells, ianalumab can help to dampen the harmful immune responses that drive autoimmune diseases.
If approved, GlobalData predicts ianalumab to reach sales of $638m in 2031.
GlobalData is the parent company of Clinical Trials Arena.
Four other pipeline drugs in Phase IIb study
The Phase IIb trial also evaluated the efficacy of four other drugs in Novartis' pipeline, namely iscalimab, remibrutinib, LYS-006 and MAS-825.
Data from the remibrutinib was presented at the American Academy of Dermatology (AAD) meeting in March 2024, with the drug having met its primary endpoint. As a result, Novartis is now running a Phase III trial of the therapy in HS (NCT06799000).
Novartis has already secured a drug in the HS treatment space, after Cosentyx (secukinumab) gained approval from the US Food and Drug Administration (FDA) in October 2023.
UCB's Bimzelx (bimekizumab) is the most recent biologic in HS, having been approved by the FDA in November 2024.
AbbVie's flagship Humira (adalimumab) is also approved in HS and was the first biologic to be approved in the indication in 2015.
"Novartis culls ianalumab in HS after Phase IIb trial failure" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
MAS is Injecting S$1.1 Billion into Small & Mid-Cap Companies: 5 Singapore Stocks That Could Benefit
There's good news for the Singapore stock market. Back in February this year, the Monetary Authority of Singapore (MAS) announced the formation of an Equities Market Review Group (EMRG) that will work on measures to improve liquidity and valuations. Just this week, MAS appointed the first three fund managers and will allocate an initial sum of S$1.1 billion under the Equity Market Development Programme (EQDP). These funds have a mandate to improve liquidity on the local bourse and broaden participation in Singapore equities, with a focus on allocation to small and mid-sized companies. Here are five such companies that we believe can benefit from this injection of liquidity. Food Empire (SGX: F03) Food Empire is a food and beverage (F&B) manufacturing and distribution group. The group's portfolio of products includes instant beverages, snack foods, and food ingredients that are sold in over 60 countries. Food Empire operates nine manufacturing facilities in six countries. The group reported a mixed set of results for 2024 with total revenue rising 11.9% year on year to US$476.3 million. Normalised net profit, however, fell by 11.4% year on year to US$50 million because of high coffee prices and higher overall expenses. A total dividend of S$0.08 was declared and paid, comprising a final dividend of S$0.06 and special dividend of S$0.02. Food Empire reported an encouraging business update for the first quarter of 2025 (1Q 2025) with total revenue rising 16.3% year on year to US$136.6 million. Earlier this month, the F&B group announced plans to invest US$37 million to expand its spray-dried soluble coffee manufacturing facility in India. Later in the month, Food Empire announced a strategic partnership with Santan to co-develop a new range of products and launch a new line of ready-to-drink beverages. ISOTeam Ltd (SGX: 5WF) ISOTeam provides repairs and redecoration (R&R) and additions and alterations (A&A) works with major customers including town councils, government bodies, and private sector building owners. For the first half of fiscal 2025 (1H FY2025) ending 31 December 2024, total revenue rose 4.2% year on year to S$65.4 million. A 28.5% year-on-year plunge in R&R revenue was more than offset by a 61.6% year-on-year surge in A&A revenue. Net profit shot up 36.5% year on year to S$1.9 million. The group's order book stood at S$188.7 million as of 11 February 2025, and will support the group's activities up till FY2029. In the medium term, ISOTeam will also offer professional end-to-end managed services to help clients build an effective robotic workforce. CSE Global (SGX: 544) CSE Global provides electrification, communications and automation solutions across different industries. The engineering group has a presence across 15 countries with 61 offices and more than 2,000 staff. For its 1Q 2025 business update, the group saw revenue inch up 4% year on year to S$205.5 million. The increase was driven by the Communications and Automation business units. Order intake, however, fell by 11.3% year on year to S$155.3 million. As a result, CSE Global's order book declined by 14.4% year on year to S$616 million. The group completed the acquisition of Chicago Communications LLC back in April 2025, but management warned that global uncertainty and inflationary pressures may continue to present uncertainties for the business. UMS Integration (SGX: 558) UMS Integration provides equipment manufacturing and engineering services to original equipment manufacturers (OEMs) of semiconductors and related equipment. The group has production facilities in Singapore, Malaysia, and the USA. For 1Q 2025, UMS Integration saw revenue rise 7% year on year to S$57.7 million. Net profit stayed flat year on year at S$9.8 million. The group declared an interim dividend of S$0.01, down from the S$0.012 paid out a year ago. Management believes the group is well-positioned to ride the wave as global fab equipment spending for front-end facilities is expected to rise this year. UMS Integration's new key customer is seeking to divert its US supply source to Asia, and the group is seeing strong order flow. In the coming months, UMS Integration will carry on with qualifications of many new product introductions for its new key customer. Frencken Group Ltd (SGX: E28) Frencken provides comprehensive original design, original equipment, and diversified integrated manufacturing solutions. The group serves customers in the aerospace, analytical life sciences, automotive, and healthcare industries. For its 1Q 2025 business review, Frencken reported revenue of S$215.8 million, 11.5% higher than the previous year. Gross margin also improved slightly to 14.8% from 13.7%. Net profit stood at S$10 million, up 12% year on year. The group does not believe that Trump's tariffs will have any major impact on its sales. Nonetheless, operating conditions may remain volatile and could be challenging. Frencken is discussing with relevant parties on supply chain adjustments and cost pass-throughs that are applicable. Back in June, Frencken's subsidiary entered into a land lease agreement of 33 years to develop a new manufacturing facility in Singapore. This site is for the expansion and consolidation of its Mechatronics manufacturing operations in Singapore. This new facility can also expand the group's capacity and scale up its business portfolio with key wafer fabrication equipment customers. As the STI hits record highs, long-term investors are asking: can dividends keep up? In this special National Day webinar, we dive into the earnings outlook for Singapore's top dividend stocks and what to expect in the months ahead. Secure your free seat here and stay ahead of the curve. What are the stock secrets to Singapore's 'quiet millionaires?' Chances are, you'll find at least one of their favourites in this free report. Download it now and see how these stocks could power your portfolio! Follow us on Facebook, Instagram and Telegram for the latest investing news and analyses! Disclosure: Royston Yang does not own shares in any of the companies mentioned. The post MAS is Injecting S$1.1 Billion into Small & Mid-Cap Companies: 5 Singapore Stocks That Could Benefit appeared first on The Smart Investor. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
USA Today
10 hours ago
- USA Today
American Eagle launches denim line with Sydney Sweeney to boost Gen Z appeal
American Eagle Outfitters AEO.N surged 10% on Thursday after unveiling a new denim campaign with Sydney Sweeney, as the apparel retailer bets on the "Euphoria" and "The White Lotus" actress to reconnect with Gen Z shoppers and boost sales. The company has partnered with Sweeney for its fall season denim collection that includes a limited-edition denim jacket as well as a "The Sydney Jean." The campaign, called "Sydney Sweeney Has Great (American Eagle) Jeans," is the company's latest effort to revive demand as it navigates muted consumer spending and higher potential costs due to tariffs. Retail industry profits: Tariffs have worried parents starting back-to-school shopping early The retail industry in the United States has been struggling to spur demand as consumers grappling with financial constraints cut back on non-essential buys, including apparel and accessories. In May, American Eagle, which primarily sources from China, pulled its annual forecasts due to tariff uncertainty. "(The campaign) is its bid to stand out more and make some noise. Denim is popular right now, so putting money behind marketing it makes sense for American Eagle," GlobalData managing director Neil Saunders said. The Sweeney partnership is not the first time a celebrity tie-up has helped drive shares of a company. In 2020, Crocs CROX.O shares jumped after singer Justin Bieber teased a collaboration with the shoe maker. American Eagle has previously teamed up with celebrities, including tennis player Coco Gauff and actress Jenna Ortega. "Well-known personalities are always an easier way to tell a story quickly. It is one of the reasons athlete endorsements work so well," BMO Capital Markets analyst Simeon Siegel said. Sweeney's campaign, which launched on Wednesday and is reportedly the company's most expensive campaign to date, will also run across the exosphere of Las Vegas's 3D display orb Sphere. American Eagle's stock was discussed on retail trader-focused social media forums including Stocktwits and Reddit, indicating interest among small-time traders who have driven up shares of retailer Kohl's KSS.N and other highly shorted names in recent days. Short interest in the company, whose shares were trading at $12 on Thursday, stood at 12.2% of public float, according to LSEG data. Reporting by Aishwarya Venugopal and Sruthi Shankar in Bengaluru; Editing by Janane Venkatraman and Shinjini Ganguli
Yahoo
17 hours ago
- Yahoo
Agentic AI systems ‘will provide enormous uplift in business performance'
Agentic artificial intelligence (AI) systems, comprising multiple agents working collaboratively, will drastically transform business performance in the coming years, according to an industry expert. Speaking on an episode of GlobalData's Instant Insights podcast, Chris Ashley, vice president for strategy at Peak, which optimises business systems using AI, predicted that agentic systems mapping back to complex business processes will provide 'enormous uplift in business performance' in the next couple of years. 'Rather than just leveraging general-purpose agents like ChatGPT's very impressive agent, we'll start to see systems that have 10, 20, 30 agents all interacting together and collaborating together to work on really, really complex tasks,' Ashley predicted. 'I'm personally really excited about that. I think this is where we'll see breakthroughs in science, in physics, on some of the world's hardest problems over the coming years.' Ashley was appearing on the podcast following OpenAI's launch of the ChatGPT agent, a consumer-facing implementation of agentic AI that can carry out complex tasks using its own reasoning. Agentic AI has been emerging as the next major iteration of the wider technology, with GlobalData analysis outlining that businesses are already 'pivoting from building deterministic workflows to implementing AI agents that learn, adapt, make decisions and perform complex tasks.' As with its launch of ChatGPT for generative AI, OpenAI's launch of the ChatGPT agentic is likely to significantly raise the profile of agentic AI in the public consciousness. 'These general-purpose agents have captured the consumer imagination and the zeitgeist AI moment,' said Ashley. 'I think, where I'm definitely interested is in that as a consumer, in these agents and the possibilities, I also really like to look at the specialised agents as well. I think they have the capacity to help us achieve really meaningful uplifts within business environments.' Agentic AI use cases Among the use cases Ashley sees for businesses are quote pricing, markdown and promotions, sales and operations planning, scenario planning within the supply chain and merchandising. 'I think that the core benefits are all focused around enhanced speed of decision making, enhanced scalability of decision making and compound returns on investment,' he explained. 'What I mean by that is we're working with manufacturers, consumer packaged goods companies and retailers around the world, and we're seeing specialised agentic capabilities being deployed now. This can be within a manufacturing environment, agentic systems for quote pricing – so businesses that respond to really large volumes of quote requests from a customer base, often a complex basket of goods.
